This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.
Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
Barthel-Index >80
Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
Written informed consent
Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
Prior regular practice of Kneipp applications
Eggensberger OHG
Lead sponsor
Bavarian Health and Food Safety Authority (LGL)
Collaborator